Related Experiment Video
Updated: Jun 24, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Vasopressin in pediatric shock and cardiac arrest
Karen Choong1, Niranjan Kissoon
1Pediatric Critical Care and Neonatology, McMaster Children's Hospital, Hamilton, Ontario, Canada. choongk@mcmaster.ca
Insights
Vasopressin shows promise for treating pediatric shock and cardiac arrest, with observational studies indicating improved blood pressure. However, use in children requires caution due to limited evidence, pending further trials.
Area of Science:
- Pediatric critical care medicine
- Pharmacology
- Cardiovascular physiology
Background:
- Vasopressin is used in adults for vasodilatory shock and cardiac arrest.
- Limited data exists on vasopressin's efficacy and safety in pediatric populations.
- Current pediatric dosing is extrapolated from adult studies.
Purpose of the Study:
- To review the physiology of vasopressin.
- To synthesize published literature on vasopressin's role in pediatric shock.
- To assess the current evidence for vasopressin use in children.
Main Methods:
- Comprehensive literature search of MEDLINE, EMBASE, and Cochrane Library (1966-2007).
- Inclusion of studies using terms: vasopressin, terlipressin, and shock in pediatrics.
- Review of reference lists and ongoing trial registries.
Main Results:
- Observational studies suggest beneficial effects of low-dose vasopressin in pediatric shock.
- Reported improvements include enhanced blood pressure and reduced catecholamine dependence.
- Evidence for vasopressin in pediatric vasodilatory shock and cardiac arrest is currently limited.
Conclusions:
- Vasopressin presents a potential therapeutic option for pediatric shock and cardiac arrest.
- Cautious administration is recommended due to limited pediatric experience.
- Results from a forthcoming randomized controlled trial in children are anticipated.
Objective:
To review the physiology and the published literature on the role of vasopressin in shock in children.
Data Source:
We searched MEDLINE (1966-2007), EMBASE (1980-2007), and the Cochrane Library, using the terms vasopressin, terlipressin, and shock and synonyms or related terms for relevant studies in pediatrics. We searched the online ISRCTN-Current Controlled Trials registry for ongoing trials. We reviewed the reference lists of all identified studies and reviews as well as personal files to identify other published studies.
Results:
Beneficial effects have been reported in vasodilatory shock and asystolic cardiac arrest in adults. Solid evidence for vasopressin use in children is scant. Observational studies have reported an improvement in blood pressure and rapid weaning off catecholamines during administration of low-dose vasopressin. Dosing in children is extrapolated from adult studies.
Conclusions:
Vasopressin offers promise in shock and cardiac arrest in children. However, in view of the limited experience with vasopressin, it should be used with caution. Results of a double-blind, randomized controlled trial in children with vasodilatory shock will be available soon.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Heart Failure Drugs: Inotropic Agents
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

